Community Research and Development Information Service - CORDIS

  • European Commission
  • Publications
  • Radiological Protection Considerations During the Treatment of Glioblastoma Patients by Boron Neuron Capture Therapy at the High Flux Reactor in Petten, the Netherlands


The BNCT clinical trial at the HFR is the first in Europe and is for the first time realised on a completely multi-national scale. BNCT is performed respecting European rules of safety and quality assurance for nuclear research reactors, for radiological protection, for radiotherapy and for clinical trials.

Additional information

Authors: MOSS R.L, JRC- HFR Unit, Petten (NL);RASSOW J, Universitõtsklinikum, Essen (DE);FINKE E, Universitõtsklinikum, Essen (DE);SAUERWEIN W, Universitõtsklinikum, Essen (DE);STECHER-RASMUSSEN F, Nuclear Research and Consultancy Group, NRG Petten (NL)
Bibliographic Reference: An oral report given at: the International Conference of the Radiological Protection of Patients. Organised by: IAEA Held in: Malaga, Spain 25-30 March, 2001
Record Number: 200013403 / Last updated on: 2001-06-27
Original language: en
Available languages: en